Catherine Stehman-Breen

Overview

Catherine Stehman-Breen received $2M in total compensation, including $288K in salary, at Sarepta Therapeutics in 2017.

Source: SEC filing on April 26, 2018.

Related executives

We found 30 more executives who work or worked at Sarepta Therapeutics.

Louise Rodino-Klapac

Sarepta Therapeutics

Chief Scientific Officer

Ian Estepan

Sarepta Therapeutics

Chief Financial Officer

Ryan Brown

Sarepta Therapeutics

General Counsel

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

Douglas Ingram

Sarepta Therapeutics

Chief Executive Officer

David Howton

Sarepta Therapeutics

General Counsel

Gilmore MMSc

Sarepta Therapeutics

Chief Scientific Officer

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

You may also like